Qingdao Haier Biomedical Co Ltd Asset Resilience Ratio

Latest as of June 2026: 9.50%

Qingdao Haier Biomedical Co Ltd asset resilience ratio. Qingdao Haier Biomedical Co Ltd (688139) has an Asset Resilience Ratio of 9.50% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688139 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥553.59 Million

≈ $81.01 Million USD Cash + Short-term Investments

Total Assets

CN¥5.83 Billion

≈ $852.63 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Qingdao Haier Biomedical Co Ltd (2019–2025)

Asset resilience ratio of Qingdao Haier Biomedical Co Ltd from 2019 to 2025. This chart shows how Qingdao Haier Biomedical Co Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of Qingdao Haier Biomedical Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Qingdao Haier Biomedical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Qingdao Haier Biomedical Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥553.59 Million	9.5%
Total Liquid Assets	CN¥553.59 Million	9.50%

Asset Resilience Insights

Limited Liquidity: Qingdao Haier Biomedical Co Ltd maintains only 9.50% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Qingdao Haier Biomedical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Qingdao Haier Biomedical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Vitrolife AB ST:VITR	Medical Devices	7.27%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Shanghai Sanyou Medical Co Ltd SHG:688085	Medical Devices	7.69%
Zhejiang Orient Gene Biotech Co Ltd SHG:688298	Medical Devices	2.82%
Nanjing Vishee Medical Technology Co Ltd SHG:688580	Medical Devices	10.74%
TAIDOC TECHNOLOGY CORP TW:4736	Medical Devices	23.03%
Dirui Industrial Co Ltd SHE:300396	Medical Devices	3.90%

Qingdao Haier Biomedical Co Ltd Asset Resilience Ratio by Year (2019–2025)

Qingdao Haier Biomedical Co Ltd asset resilience ratio by year from 2019 to 2025. The table below shows the annual Asset Resilience Ratio data for Qingdao Haier Biomedical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	7.73%	CN¥447.59 Million ≈ $65.50 Million	CN¥5.79 Billion ≈ $847.48 Million	-7.43pp
2024-12-31	15.16%	CN¥877.25 Million ≈ $128.37 Million	CN¥5.79 Billion ≈ $846.89 Million	+3.37pp
2023-12-31	11.78%	CN¥651.14 Million ≈ $95.28 Million	CN¥5.53 Billion ≈ $808.58 Million	-25.08pp
2022-12-31	36.87%	CN¥2.02 Billion ≈ $296.12 Million	CN¥5.49 Billion ≈ $803.21 Million	-6.60pp
2021-12-31	43.47%	CN¥2.13 Billion ≈ $311.65 Million	CN¥4.90 Billion ≈ $717.00 Million	+33.12pp
2020-12-31	10.35%	CN¥408.03 Million ≈ $59.71 Million	CN¥3.94 Billion ≈ $576.93 Million	+5.97pp
2019-12-31	4.38%	CN¥133.05 Million ≈ $19.47 Million	CN¥3.04 Billion ≈ $444.85 Million	--

pp = percentage points

About Qingdao Haier Biomedical Co Ltd

SHG:688139 China Medical Devices

Market Cap

$1.55 Billion

CN¥10.56 Billion CNY

Market Cap Rank

#6856 Global

#1386 in China

Share Price

CN¥33.38

Change (1 day)

-1.45%

52-Week Range

CN¥24.70 - CN¥37.36

All Time High

CN¥147.76